Ucla Health Joins Nationwide Clinical Trial For Acute Myeloid Leukemia | Latest News RSS feed

Ucla Health Joins Nationwide Clinical Trial For Acute Myeloid Leukemia - Latest News


UCLA Health joins nationwide clinical trial for acute myeloid leukemia

UCLA Health has joined an important national clinical trial that uses genetic testing to match people who have acute myeloid leukemia, or AML, with new therapies. UCLA’s hospital system is the first ... read more

Huntsman Cancer Institute joins national clinical trial targeting AML

The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML ... The Beat AML trial hopes to recruit 500 patients nationwide and includes ... read more

Renowned blood-cancer specialist joins UAB

“He is a prominent leader in field of leukemia, a distinguished educator and has been involved in the development and clinical trials of numerous new therapeutic ... Practice Guidelines committees for ... read more

Looking for another news?


Accelerated Clinical Trials Bridging Gateway to Latest Treatments for Cancer Patients

Active biotech and pharma companies in the markets this week include Moleculin Biotech, Inc. MBRX, -1.68% Seelos Therapeutics, Inc. SEEL, -0.72% (elanco animal health ... acute myeloid leukemia (AML). ... read more


Bringing a leukemia treatment back to life with precision medicine

After a more extensive FDA-required clinical trial showed no clear evidence of the drug ... regimen in pediatric and young adult patients with newly diagnosed acute myeloid leukemia, or AML. The ... read more

Kiadis to Acquire CytoSen Therapeutics, Inc.

It was founded on technology exclusively licensed from the University of Central Florida (UCF) and further developed at Nationwide ... Transplant Clinical Trials Network (BMT CTN). The study will ... read more

State Highlights: Georgia’s Doctors Have Pessimistic View Of Future; Right-To-Die Measure Nears Vote By D.C. Council

Less than 20 percent of patients older than 60 with acute myeloid leukemia — a disease of the blood and ... But by the end of the year, the OSU center will help launch a massive, nationwide clinical ... read more

Dr. Henry A. McKinnell Jr., Former Pfizer CEO, Joins Emmaus Medical, Inc. Board of Directors

Emmaus Medical, Inc. is now in phase 3 clinical trials with its patented L-glutamine treatment ... results Daiichi Sankyo hopes will win it approval for quizartinib in acute myeloid leukemia. ... read more

SHOP TALK

Lili Yang, PhD, Assistant Professor of Microbiology, Immunology, and Molecular Genetics at UCLA Jonsson Comprehensive Cancer Center, has received a National Institutes of Health ... on specific ... read more

American Cancer Society awards 143 research grants to investigators at 83 institutions nationwide

has discovered a novel target for treatment of acute myeloid leukemia (AML), a devastating cancer of the ... tumor vaccine could be the basis for future breast cancer clinical trials, particularly for ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us